Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cullinan Therapeutics, Inc.(CGEM) | 7,648,268 | 7,648,268 | 0 | $69.22M | $77.94M | 18.23% | +$8.72M |
| Iovance Biotherapeutics, Inc.(IOVA) | 3,287,397 | 3,289,470 | +2,073 | $14.96M | $26.74M | 6.26% | +$11.79M |
| Olema Pharmaceuticals, Inc.(OLMA) | 1,857,681 | 1,857,136 | -545 | $22.94M | $26.06M | 6.10% | +$3.11M |
| Geron Corporation(GERN) | 10,712,481 | 10,715,620 | +3,139 | $22.71M | $22.61M | 5.29% | -$100.5K |
| iTeos Therapeutics, Inc. | 1,745,943 | 1,745,943 | 0 | $19.12M | $19.12M | 4.47% | $0 |
| ALX Oncology Holdings Inc.(ALXO) | 0 | 1,264,759 | +1,264,759 | $0 | $18.83M | 4.41% | +$18.83M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 294,190 | 294,576 | +386 | $16.77M | $17.79M | 4.16% | +$1.02M |
| Crinetics Pharmaceuticals Inc. | 479,053 | 478,234 | -819 | $14.25M | $17.02M | 3.98% | +$2.77M |
| Karuna Therapeutics Inc | 53,210 | 53,279 | +69 | $9.00M | $16.86M | 3.95% | +$7.87M |
| Insmed Incorporated(INSM) | 527,458 | 528,150 | +692 | $13.32M | $16.37M | 3.83% | +$3.05M |
| Cymabay Therapeutics Inc | 610,770 | 611,181 | +411 | $9.11M | $14.44M | 3.38% | +$5.33M |
| Repare Therapeutics, Inc. | 1,639,849 | 1,639,849 | 0 | $19.81M | $11.97M | 2.80% | -$7.84M |
| Intellia Therapeutics, Inc.(NTLA) | 544,639 | 382,598 | -162,041 | $17.22M | $11.67M | 2.73% | -$5.56M |
| Amicus Therapeutics Inc. COM | 716,139 | 715,883 | -256 | $8.71M | $10.16M | 2.38% | +$1.45M |
| REGENXBIO Inc.(RGNX) | 656,718 | 549,078 | -107,640 | $10.81M | $9.86M | 2.31% | -$953.6K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 40,859 | 40,910 | +51 | $5.97M | $9.47M | 2.21% | +$3.50M |
| Structure Therapeutics Inc.ADS | 230,761 | 230,696 | -65 | $11.63M | $9.40M | 2.20% | -$2.23M |
| Avadel Pharmaceuticals PLCADR | 664,224 | 664,986 | +762 | $6.84M | $9.39M | 2.20% | +$2.55M |
| Morphic Holding Inc | 200,000 | 323,742 | +123,742 | $4.58M | $9.35M | 2.19% | +$4.77M |
| Werewolf Therapeutics, Inc.(HOWL) | 2,388,011 | 2,388,011 | 0 | $5.11M | $9.22M | 2.16% | +$4.11M |
| Relay Therapeutics, Inc.(RLAY) | 1,352,133 | 832,017 | -520,116 | $11.37M | $9.16M | 2.14% | -$2.21M |
| Xeris Biopharma Holdings Inc | 3,987,967 | 3,847,232 | -140,735 | $7.42M | $9.04M | 2.12% | +$1.62M |
| Verve Therapeutics, Inc | 857,940 | 638,163 | -219,777 | $11.38M | $8.90M | 2.08% | -$2.48M |
| Revolution Medicines, Inc.(RVMD) | 273,408 | 273,408 | 0 | $7.57M | $7.84M | 1.83% | +$273.4K |
| Axsome Therapeutics, Inc.(AXSM) | 93,586 | 93,387 | -199 | $6.54M | $7.43M | 1.74% | +$891.9K |
| Viking Therapeutics, Inc.(VKTX) | 325,000 | 325,284 | +284 | $3.60M | $6.05M | 1.42% | +$2.46M |
| Adaptimmune Therapeutics plcADR(ADAPY) | 5,095,912 | 5,095,912 | 0 | $3.97M | $4.04M | 0.95% | +$66.2K |
| Harpoon Therapeutics, Inc. | 319,670 | 319,670 | 0 | $1.29M | $3.63M | 0.85% | +$2.35M |
| Disc Medicine, Inc.(IRON) | 0 | 50,000 | +50,000 | $0 | $2.89M | 0.68% | +$2.89M |
| Viridian Therapeutics, Inc.(VRDN) | 255,323 | 100,000 | -155,323 | $3.92M | $2.18M | 0.51% | -$1.74M |
| Inozyme Pharma Inc. | 326,921 | 323,813 | -3,108 | $1.37M | $1.38M | 0.32% | +$6.4K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 347,332 | 70,000 | -277,332 | $3.60M | $639.1K | 0.15% | -$2.96M |
| Kalvista Pharmaceuticals IncCommon | 577,958 | 0 | -577,958 | $5.57M | $0 | — | -$5.57M |
| Travere Therapeutics Inc.Common(TVTX) | 552,846 | 0 | -552,846 | $4.94M | $0 | — | -$4.94M |